SBI Securities’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$593 Sell
104
-46
-31% -$199 ﹤0.01% 2990
2026
Q1
$581 Buy
150
+22
+17% +$90 ﹤0.01% 2833
2025
Q4
$535 Buy
128
+15
+13% +$58 ﹤0.01% 2850
2025
Q3
$372 Buy
113
+1
+0.9% +$3 ﹤0.01% 3097
2025
Q2
$159 Hold
112
﹤0.01% 3383
2025
Q1
$167 Sell
112
-190
-63% -$299 ﹤0.01% 3282
2024
Q4
$338 Buy
+302
New +$258 ﹤0.01% 3035

Other funds holding PGEN

SBI Securities's PGEN Position: Q2 2026 in Review

SBI Securities reduced its Precigen (PGEN) stake by 31% in Q2 2026, selling an estimated $199 and leaving 104 shares worth $593. The position accounts for ﹤0.01% of the portfolio, ranked #2990.

SBI Securities first reported a position in PGEN in Q4 2024 and has held it in 7 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • SBI Securities held 104 shares of Precigen worth $593 as of Q2 2026.
  • SBI Securities sold 46 Precigen shares in Q2 2026, an estimated $199.
  • Precigen made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2990 holding.
  • SBI Securities first reported a position in Precigen in Q4 2024 and has held it in 7 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.